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Background: The purpose of this study was to investigate the mechanism of noxious effects 
of amorphous silica nanoparticles on human endothelial cells.
Methods: Nanoparticle uptake was examined by transmission electron microscopy. 
  Electrochemical nanosensors were used to measure the nitric oxide (NO) and peroxynitrite 
(ONOO−) released by a single cell upon nanoparticle stimulation. The downstream inflammatory 
effects were measured by an enzyme-linked immunosorbent assay, real-time quantitative 
polymerase chain reaction, and flow cytometry, and cytotoxicity was measured by lactate 
dehydrogenase assay.
Results: We found that the silica nanoparticles penetrated the plasma membrane and rapidly 
stimulated release of cytoprotective NO and, to a greater extent, production of cytotoxic ONOO−. 
The low [NO]/[ONOO−] ratio indicated increased nitroxidative/oxidative stress and correlated 
closely with endothelial inflammation and necrosis. This imbalance was associated with nuclear 
factor κB activation, upregulation of key inflammatory factors, and cell death. These effects 
were observed in a nanoparticle size-dependent and concentration-dependent manner.
Conclusion: The [NO]/[ONOO−] imbalance induced by amorphous silica nanoparticles 
  indicates a potentially deleterious effect of silica nanoparticles on vascular endothelium.
Keywords: amorphous silica nanoparticles, nanotoxicology, nitric oxide, peroxynitrite, 
  inflammation, risk factors
Introduction
The use of synthetic amorphous silicon dioxide or silica nanoparticles in medicine 
is becoming increasingly accepted for a variety of therapeutic, diagnostic, and 
imaging applications.1,2 This adds to the already significant industrial exposure to 
silica nanoparticles during production, storage, transportation, and consumer use.3 It 
is increasingly recognized that amorphous silica nanoparticles induce cytotoxicity.4 
However, genotoxicity induced by amorphous silica nanoparticles seems to be cell-line 
dependent.5–7 Overall, little is known about the toxicological effects of nanoparticles 
on the vasculature.
This study elucidates a direct interaction between engineered amorphous 
silica nanoparticles (10 nm, 10SiNP; 50 nm, 50SiNP; 150 nm, 150SiNP; 500 nm, 
500SiNP) and primary human umbilical vein endothelial cells (HUVECs). This cell 
line has been used as a reference for in vitro studies of endothelial cell function, 
since Jaffe et al8 developed a procedure to isolate them from the umbilical cord International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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by collagenase   digestion. Direct release of nitric oxide 
(NO) and peroxynitrite (ONOO−) during nanoparticle-cell 
interactions was measured by nanosensors. NO is essential 
for vascular homeostasis and disease.9 Endothelial cells and 
platelets generate NO which induces vasorelaxation, and with 
prostacyclin synergistically regulates vascular hemostasis by 
inhibiting platelet adhesion and aggregation.10–13 Impairment 
of NO bioavailability is one of the earliest events in vascular 
disease,9,14 and may result from decreased NO   synthesis 
and/or increased superoxide (O2•−) generation. Superoxide 
reacts rapidly with NO, producing ONOO−, a strong 
  cytotoxic agent.15 High ONOO− production and depleted NO 
  availability resulting in a low ratio (,1.0) of maximal NO 
to maximal ONOO− concentrations ([NO]/[ONOO−]) can 
be used accurately as an indicator of nitroxidative/oxidative 
stress and endothelial dysfunction.16–18 It has been suggested 
that oxidative stress induces upregulation of gene expression 
by transcription factor activation.19 When activated, these 
factors initiate the transcription of several genes involved in 
inflammation and coagulation.20,21 For instance, endothelial 
adhesion molecules, intercellular adhesion molecule 1 
(ICAM1),22 vascular cell adhesion molecule 1 (VCAM1),23 
and selectin E (SELE),24 provide cell–cell adhesion between 
the endothelium and leukocytes. Matrix metalloproteinase 9 
(MMP9)25,26 digests various components of the extracellular 
matrix, such as type IV collagen, gelatin, and elastin, 
allowing leukocyte accommodation after diapedesis. Cyclo-
oxygenase (COX) 2 mediates generation of COX-derived 
endothelium-derived constrictors and relaxants by converting 
arachidonic acid to prostaglandin H2.20 Tissue factor (F3) 
is a key initiator of the coagulation cascade synthesized by 
endothelium in response to various stimuli.27 Interleukin 6 
(IL6) has proatherogenic effects.28,29 Interleukin 8 (IL8) is 
involved in neutrophil chemotaxis and has proatherogenic 
and proinflammatory effects.29 Therefore, we studied the 
effects of amorphous silica nanoparticles on nitroxidative/
oxidative stress, inflammatory mediators, and cytotoxicity 
in primary HUVECs. Our results indicate that the [NO]/
[ONOO−] imbalance induced by silica nanoparticles may 
underpin the mechanism of cytotoxicity of amorphous silica 
nanoparticles in human endothelial cells.
Materials and methods
reagents
All reagents were purchased from Sigma-Aldrich (Arklow, 
Ireland) unless indicated. Amorphous silica nanoparticles 
with different sizes (10SiNP, 50SiNP, 150SiNP, 500SiNP) 
were purchased from Polysciences (Eppelheim, Germany).
Zeta potential measurement
The zeta potentials of all the silica nanoparticles were 
determined by a Zetasizer Nano ZS (Malvern Instruments, 
Worcestershire, UK). Measurements were performed six 
times for each particle size (100 µg/mL in ultrapure water) 
at room temperature.
Transmission electron microscopy
The nanoparticle suspensions (10 µg/mL in ultrapure water) 
were examined using a JEM 2100 transmission electron 
microscope (JEOL, Hertfordshire, UK). The diameter of 
100 nanoparticles of each size seen on three transmission 
electron micrographs was measured using Image J, an 
  open-source, Java-based imaging software (http://rsbweb.
nih.gov/ij/). The shape of irregular nanoparticles was adjusted 
to a sphere before measurement.
Cell culture
Primary prescreened HUVECs were purchased from the 
Health Protection Agency Culture Collections (ECACC, 
Salisbury, UK). Cells were cultured in the recommended 
ECACC complete endothelial cell growth medium and 
maintained at 37°C in a 5% CO2 humidified incubator. Cells 
were supplied with fresh medium every 2 days and propa-
gated using the recommended ECACC subculture kit, for a 
maximum of 16 population doublings.
Cell exposure to silica nanoparticles
Primary HUVECs were exposed to amorphous silica 
  nanoparticles suspended in basal media (ECACC complete 
media without serum or growth factors) supplemented with 
2% fetal bovine serum and 0.03 mg/mL endothelial cell 
growth supplements. Immediately before use,   commercial 
stock suspensions were sonicated for 2 minutes, and 
  nanoparticle dispersions in culture media were prepared by 
serial dilution from these stock suspensions by vortexing. 
Controls were supplied with an equivalent volume of media 
without nanoparticles.
Transmission electron microscopy  
of primary hUVeCs
The silica nanoparticle-endothelial cell interaction was stud-
ied by transmission electron microscopy. At 80%   confluence, 
HUVECs seeded into 75 cm2 tissue culture flasks were 
incubated with 10 µg/mL 10SiNP for 1 hour. Thereafter, 
cells were collected in basal media and fixed by mix-
ing with an equal volume of 3% glutaraldehyde in 0.05 
M potassium phosphate buffer (pH 6.8) for 1.5 hours at International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2823
Toxicity of amorphous silica nanoparticles
room temperature. After primary fixation, samples were 
  centrifuged and the pellets were washed six times with 
0.05 M potassium phosphate buffer (pH 6.8). The pellets 
were then post-fixed with 2% osmium tetroxide in 0.05 M 
potassium phosphate buffer (pH 6.8) for 30 minutes. Pellets 
were then dehydrated in series of graded ethanol solutions, 
infiltrated, and embedded in agar 100 epoxy resin, using 
propylene oxide as a transitional fluid. Next, ultrathin sections 
were cut from dried blocks with a diatom diamond knife on 
an LKB   Ultratom III (LKB, Uppsala, Sweden), stained with 
0.5% aqueous uranyl acetate followed by Reynold’s lead 
citrate. Finally, the sections were examined using a JEM 
2100 transmission electron microscope.
Measurement of NO and ONOO− 
concentrations using nanosensors
Concurrent NO and ONOO− measurements were performed 
with electrochemical nanosensors (diameter 300–500 nm). 
The designs were based on previously developed and 
well characterized chemically modified carbon fiber 
technology.30,31 Each of the sensors was made by depositing a 
sensing material on the tip of the carbon fiber, ie, a conductive 
film of polymeric nickel (II) tetrakis (3-methoxy-4-
hydroxy-phenyl) porphyrin for the NO sensor and a 
polymeric film of Mn (III)–paracyclophanyl-porphyrin for 
the ONOO−   sensor. Amperometry was used to measure 
changes in NO and ONOO− concentrations from basal 
levels with time   (detection limit of 1 nM and resolution 
time ,10 µsec for each sensor). Linear calibration curves 
were constructed for each sensor from 5 nM to 3 µM 
before and after measurements with aliquots of NO and 
ONOO− standard solutions.   Nanosensors were positioned 
at 5 ± 2 µm from the cell membrane of a   single endothelial 
cell. A calcium ionophore, A23187 (1 µM), was used to 
stimulate the maximal release of NO and ONOO− from a 
single cell in the absence of nanoparticles.
Fluorescence microscopy
Primary HUVECs were plated into six-well plates. The 
next day, following 1 hour of incubation with 10SiNP 
(10 µg/mL), cells were incubated with 5-(and 6)-carboxy-
2′,7′-  difluorodihydrofluorescein diacetate (Invitrogen, 
  Paisley, UK) in basal media for 30 minutes in a 37°C, 
5% CO2 humidified incubator. A control in the absence of 
  nanoparticles was also prepared. Adhesive cells were then 
washed twice with basal media and examined under an 
  Axiovert 200 M inverted fluorescence microscope (Carl Zeiss, 
  Welwyn Garden City, UK) at λ ex/λ em 485/530 nm.
Measurement of NF-κB binding activity
To evaluate the influence of silica nanoparticles on NF-κB 
binding activity, a specific enzyme-linked immunosorbent 
assay was performed on nuclear extracts from HUVECs 
(into 75 cm2 tissue culture flasks). Cells were exposed to 
10SiNP (10 µg/mL) for 1 hour, and 50SiNP, 150SiNP, and 
500SiNP (50 µg/mL) for 3 hours. Controls in the absence 
of nanoparticles were also prepared.
Purification of nuclear extracts
Following incubation, nuclear proteins were isolated 
using a nuclear extraction kit (Cayman, Dublin, Ireland). 
The isolation was performed following the supplier’s 
recommendations. Briefly, cells were washed once and 
then collected in a phosphate-buffered saline/phosphatase 
inhibitor solution. Cells were centrifuged and the pellets 
were washed twice with the same solution. The pellets were 
incubated for 15 minutes in a hypotonic buffer (containing 
both phosphatase and protease inhibitors) to allow the cells to 
swell. Nonidet®-P40 assay reagent was then added to disturb 
the plasma membrane, and the samples were centrifuged. 
Pellets (nuclei) were incubated with a nuclear extraction 
buffer (containing both phosphatase and protease inhibitors) 
to disturb the nuclear membrane, and then centrifuged. 
Nuclear fractions, contained in the supernatants, were stored 
at −80°C. Protein concentration, in the nuclear extracts, was 
spectrometrically determined (λ 595 nm) by Bradford’s 
method.
Measurement of NF-κB (p65) DNA binding activity
The binding activity of the p65 subunit of the transcription 
factor, NF-κB, was assessed using a NF-κB (p65) transcrip-
tion factor assay kit (Cayman). This enzyme-linked immu-
nosorbent assay was performed following the supplier’s 
recommendations. Briefly, nuclear fractions, containing 
30 µg of proteins were mixed with a binding buffer and then 
loaded into a duplicate set of wells in a 96-well plate. The 
wells hold a specific double-stranded DNA containing the 
NF-κB response element immobilized onto the bottom. Follow-
ing overnight incubation, samples were washed five times 
and then incubated for 1 hour at room temperature with an 
anti-p65 antibody. Samples were further washed five times 
and then incubated for 1 hour at room temperature with a 
goat antirabbit horseradish peroxidase-conjugated antibody. 
Samples were again washed five times. A developing solution 
was added, and the plate was incubated for 15–45 minutes at 
room temperature with gentle agitation and protected from 
light. Following the addition of the stop solution, absorbance International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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was read at λ 450 nm. The NF-κB DNA binding activity 
induced by each nanoparticle was expressed relative to the 
control sample. Further experiments were performed with 
silica nanoparticles only to rule out the possibility of particle 
interference in the assessment.
real-time quantitative polymerase  
chain reaction
The effect of silica nanoparticles on the gene expression of key 
inflammatory factors was assessed by real-time   quantitative 
polymerase chain reaction. Primary HUVECs (in six-well 
plates) were exposed to various concentrations of silica 
nanoparticles for 3, 7, and 15 hours. Controls in the absence 
of nanoparticles were also prepared. Following incubation, 
the cells were washed twice with phosphate-buffered saline. 
DNA-free RNA was isolated using an Ambion RNAqueous®-
4PCR kit (Applied Biosystems, Warrington, UK) according 
to the supplier’s recommendations. Thereafter, isolated RNA 
in each sample was quantified using a NanoDrop® ND-1000 
spectrophotometer (Fisher Scientific, Dublin, Ireland). An 
equal quantity of total DNA-free RNA from each sample 
was reverse-transcribed using a high capacity cDNA reverse 
transcription kit (Applied Biosystems). Reverse transcription 
was performed using a Realplex2 Mastercycler (Eppendorf, 
Cambridge, UK). Finally, an equal quantity of total cDNA 
of each sample was used to performed real-time quantitative 
polymerase chain reaction in duplicate, with predesigned 
Applied Biosystems TaqMan® gene expression assays for 
ICAM1, VCAM1, SELE, MMP9, COX2, F3, IL6, and IL8, 
and Applied Biosystems TaqMan Universal PCR Master Mix; 
18S ribosomal ribonucleic acid (18S rRNA) was used as an 
internal control. Real-time quantitative polymerase chain 
reaction was performed using a Realplex2 Mastercycler. The 
expression of each gene, within each sample, was normalized 
against 18S rRNA expression and expressed relative to the 
control sample using the formula 2−(∆∆Ct), in which ∆∆Ct = (Ct 
mRNA − Ct 18S rRNA) sample − (Ct mRNA − Ct 18S rRNA) 
control.32 Further experiments were performed with the silica 
nanoparticles only to rule out the possibility of nanoparticle 
interference with this technique.
Lactacystin and real-time quantitative 
polymerase chain reaction
Involvement of NF-κB in gene upregulation induced by 
silica nanoparticles was studied by real-time quantitative 
polymerase chain reaction. HUVECs (in six-well plates) 
were incubated with lactacystin (1 µM) which suppresses 
NF-κB binding activity for 1 hour followed by exposure to 
10 µg/mL 10SiNP for 15 hours. Controls in the absence of 
nanoparticles and nanoparticle-treated samples in the absence 
of lactacystin were also prepared. After incubation, DNA-
free RNA was isolated and real-time quantitative polymerase 
chain reaction was performed as above.
Cytometric bead array
A cytometric bead array human inflammatory cytokine kit 
(Becton Dickinson, Oxford, UK) was used to quantify IL6 
and IL8 protein levels in the supernatants. Experiments 
were performed using a FACSArray™ bioanalyzer (Becton 
Dickinson). Cells (in six-well plates) were incubated with 
various concentrations of silica nanoparticles (10, 50, 
150, and 500 nm) for 15 hours. Controls in the absence of 
nanoparticles were also prepared. Assays were performed 
following the supplier’s recommendations. Briefly, captured 
beads (50 µL) coated with specific antibodies for the 
cytokines, supernatant samples (50 µL), and phycoerythrin 
detection reagent (50 µL) were mixed together and incubated 
at room temperature for 3 hours in the dark. Following 
washing, sample data were acquired by Becton Dickinson 
analysis software, and analyzed by FCAP Array™ software. 
The cytokine concentration was obtained using a calibration 
curve of human inflammation standards. Cytokine release 
induced by each nanoparticle was expressed relative to the 
control sample. Further experiments were performed with 
the silica nanoparticles only to rule out the possibility of 
nanoparticle interference with the technique.
Assessment of toxicity
To evaluate the cytotoxicity of the silica nanoparticles, 
HUVECs were seeded into 96-well round-bottom plates, 
and the lactate dehydrogenase (LDH) assay was performed. 
The activity of extracellular LDH release upon cell lysis was 
  measured using a CytoTox96® nonradioactive cytotoxicity 
assay (Promega, Southampton, UK). Cells were exposed to 
various concentrations of 10SiNP, 50SiNP, 150SiNP, and 
500SiNP (LDHexp) in triplicate. The percentage of cell 
  viability was determined 3, 7, 15, and 30 hours post-treatment. 
Triplicate control wells in the absence of nanoparticles were 
also   prepared (LDHcon). We also performed a positive 
LDH control supplied with the LDH assay to verify that 
the assay was functioning properly. Assays were performed 
following the supplier’s recommendations. Briefly, after 
exposure of the cells to the nanoparticles, 50 µL of the 
cell culture supernatants and 50 µL of substrate mix were 
mixed together in a 96-well plate. Samples were incubated 
for 30 minutes in the dark. LDH activity was measured International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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spectrophotometrically at λ 492 nm following addition of 
a stop solution (50 µL). A set of triplicate wells containing 
untreated controls was lyzed to extract the maximum LDH 
activity (LDHmax). A set of triplicate wells containing 
medium with neither nanoparticles nor cells was prepared 
(culture medium background). A set of triplicate wells was 
prepared to correct for volume changes caused by addition 
of lysis solution (volume correction control). The average 
of the absorbance values of the culture medium background 
was subtracted from the average of LDHcon and LDHexp. 
The average absorbance values for volume correction control 
was subtracted from LDHmax. Afterwards, the percentage 
of cell viability induced by each nanoparticle was expressed 
relative to the control sample according to the formula:
  %
exp)
max)
viability
(LDH LDHcon
(LDH LDHcon
=−
−
−
× 




 100 100
statistical analysis
All data are presented as the mean ± standard error of the 
mean of n . 3. Statistical analysis of the mean difference 
between multiple groups was determined by one-way analy-
sis of variance followed by Tukey–Kramer multiple compari-
son tests, and between two groups by two-tailed Student’s 
t-tests. The alpha level for all tests was 0.05. A P value ,0.05 
was considered to be statistically significant. All statistical 
analyses were performed using GraphPad Prism (v 5.00 for 
Windows; GraphPad Software, San Diego, CA) and Origin 
(v 6.1 for Windows; OriginLab, Northampton, MA).
Results
Characterization of silica nanoparticles
Accurate and careful physicochemical characterization 
of nanoparticles before assessing their in vitro toxicity 
is of crucial importance.33 As specified by the supplier, 
the commercially available negative surface-charged 
silica nanoparticles used in our studies (10SiNP, 50SiNP, 
150 SiNP, and 500 SiNP) were uniform amorphous solid 
(nonporous) pure silicon dioxide made via a precipitation 
process. Our transmission electron microscopy studies 
showed that the larger particles (150SiNP and 500SiNP) had 
a spherical shape, while the shape of the smaller particles 
(10SiNP and 50SiNP) was more irregular (Figure 1A–D). 
Because significant deviations from nominal specifications 
are usual in commercially supplied samples,34 we used 
ImageJ software to measure particle diameter on transmission 
electron micrographs of nanoparticles to confirm the 
size specified by the vendor (Table 1). We also used a 
light scattering technique (Zetasizer) to measure the zeta 
potentials of the silica nanoparticles (Table 1). All the 
nanoparticles tested in our study had zeta potentials more 
negative than −30 mV .
Internalization of amorphous silica 
nanoparticles into hUVeCs
We performed transmission electron microscopy to study 
silica nanoparticle-endothelial cell interactions and uptake. 
After 1 hour of coincubation, we found that the amorphous 
silica nanoparticles (10 µg/mL, 10 nm) were taken up 
by primary HUVECs (Figure 1E–G). Indeed, the nano-
particles interacted quickly with the plasma membrane 
(Figure 1E and F), internalized, and distributed into the 
cytoplasm of the cells (Figure 1F and G). Moreover, the 
nanoparticles were found mainly encapsulated in vesicles. 
However, nonencapsulated nanoparticles were also observed. 
  Furthermore, nanoparticles were observed forming agglom-
erates   (Figure 1E–G).
A B
CD
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Figure 1 Uptake of amorphous siNP by primary human umbilical vein endothelial 
cells.  electron  micrographs  of  10siNP  (A),  50siNP  (B),  150siNP  (C),  and 
500siNP (D), in ultrapure water. As shown by transmission electron microscopy, 
after exposure of endothelial cells to 10 µg/mL of 10siNP for 1 hour, nanoparticles 
quickly interacted with the plasma membrane, internalized, and distributed within 
the cytoplasm (E–G). They were found mainly encapsulated in vesicles, but also 
free in the cytosol (F and G). scale bars represent 50 nm (A, B, C, and D), 100 nm 
(E and G), and 500 nm (F).
Abbreviations:  siNP,  silica  nanoparticles;  ePM,  endothelial  plasma  membrane; 
eNM, endothelial nuclear membrane; Vs, vesicle.International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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Imbalanced [NO]/[ONOO−] ratio in 
hUVeCs causes nitroxidative/oxidative 
stress and endothelial dysfunction
It has been suggested that nanoparticle-cell interactions may 
lead to oxidative stress and oxidant injury.35–37 Depleted NO 
and high ONOO− production by cells resulting in a low ratio 
(,1.0) of maximal NO to maximal ONOO− concentrations 
have been used as an accurate indicator of oxidative stress 
leading to dysfunctional endothelium.16,18 Therefore, 
we   studied in situ real-time dynamic interaction of the 
amorphous silica nanoparticles with primary HUVECs by 
measuring NO and ONOO− concentrations directly using 
nanosensors placed 5 ± 2 µm from the plasma membrane 
of a single cell. We demonstrated with time resolution 
better than 10 microseconds that these nanoparticles rapidly 
stimulated NO release, followed by ONOO− production after 
collision with cells (Figure 2A). The rate of NO production 
was in reverse proportion to nanoparticle size and directly 
proportional to particle concentration (Figure 2B). The 
silica nanoparticle-stimulated generation of cytoprotective 
and vasodilatory NO was followed by massive production of 
strongly oxidant and cytotoxic ONOO−, a major component 
of oxidative stress. When the nanoparticle concentrations 
were increased, a rapid exponential rate of ONOO− release 
from endothelial cells was observed for 10SiNP, and a 
sigmoid rate for 50SiNP (Figure 2C). The increase in rate 
of production of ONOO− with increasing concentrations 
was much the lower for larger nanoparticles (150SiNP 
and 500SiNP, Figure 2C). Exposure of endothelial cells 
to amorphous silica nanoparticles shifted the balance of 
maximal [NO]/[ONOO−] unfavorably. Indeed, the smallest 
nanoparticles (10 nm) at 10 µg/mL significantly reduced the 
ratio of [NO]/[ONOO−] for 5–6 times as compared with the 
larger particles (Figure 2D). Moreover, the [NO]/[ONOO−] 
ratio was decreased in a size-dependent manner by an 
equal concentration (100 µg/mL) of 50SiNP, 150SiNP, 
and 500SiNP (Figure 2E). We obtained a   maximal 
[NO]/[ONOO−] ratio (higher than 2) upon stimulation 
of HUVECs with a calcium ionophore (A23187) in the 
absence of nanoparticles. The low [NO]/[ONOO−] balance 
(,1.0) derived from exposure of primary HUVECs to 
silica   nanoparticles is indicative of high nitroxidative/
oxidative stress and endothelial dysfunction. This effect 
was of highest significance for nanoparticles smaller 
than 50 nm.
In addition to our direct measurements with nanosensors, 
we also used fluorescence microscopy to verify indirectly the 
ability of amorphous silica nanoparticles to induce oxida-
tive stress in treated endothelial cells (Figure 3). Moreover, 
the corresponding phase-contrast micrographs suggest cell 
death as a result of necrosis induced by silica nanoparticles, 
because HUVECs detached from the cell culture dish after 
particle exposure (Figure 3).
endothelial NF-κB activation and 
upregulation of inflammatory factors
Because oxidative stress may lead to activation of 
transcription factors,19 we studied the effect of the amor-
phous silica nanoparticles on NF-κB DNA binding activity. 
We show that 10SiNP (10 µg/mL) induced increased 
endothelial NF-κB activity after only 1 hour of exposure 
to cells, when compared with controls in the absence 
of nanoparticles. Furthermore, 50SiNP and 150SiNP 
(50 µg/mL) also increased transcription factor activity in 
3 hours. In contrast, 500SiNP (50 µg/mL) did not affect 
this activity in 3 hours (Figure 4). The endothelial NF-κB 
Table 1 silica nanoparticle characterization. Nanoparticle properties (stock suspension concentration, size, surface charge, particles 
per milliliter, particles per gram, composition, synthesis, and porosity)
10SiNP 50SiNP 150SiNP 500SiNP
Concentration (mg/mL)* 50.0 57.0 100.0 100.0
size (nm)* 10.0 50.0 150.0 500.0
size (nm)† 10.50 ± 0.19 52.67 ± 0.66 148.20 ± 2.19 495.90 ± 5.87
surface charge* Negative Negative Negative Negative
Zeta potential (mV)# −43.44 ± 1.75 −38.33 ± 0.20 −38.43 ± 0.30 −39.29 ± 0.12
Particles per mL* 4.90 × 1016 3.92 × 1014 2.99 × 1013 7.42 × 1011
Particles per gram* 9.55 × 1017 7.64 × 1015 2.83 × 1014 7.20 × 1012
Composition* Pure siO2 Pure siO2 Pure siO2 Pure siO2
synthesis* Precipitated Precipitated Precipitated Precipitated
synthesis* Colloidal Colloidal – –
Porosity* Nonporous Nonporous Nonporous Nonporous
Notes: *supplied by the manufacturer, as well as re-evaluated by †transmission electron microscopy (size) and by #Zetasizer (zeta potential) in ultrapure water.
Abbreviation: siNP, silica nanoparticles.International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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Figure 2 Amorphous siNP induce NO and ONOO− production and unfavorably shift the [NO]/[ONOO−] balance in primary human umbilical vein endothelial cells. 
(A) representative recordings of NO and ONOO− concentrations measured in situ by specific nanosensors placed 5 ± 2 µm for the surface of a single cell after addition of 
25 µg/mL 10siNP (arrows) to the cell culture media. Maximal concentration of NO (B) and ONOO− (C) released from cells following stimulation by 10siNP (), 50siNP 
(), 150siNP (•), and 500siNP (°). All values are presented as the mean ± standard error of the mean of n = 4. One-way analysis of variance and Tukey–Kramer multiple 
comparison tests were used to analyze all sets of data. [NO]/[ONOO−] ratio of the maximal NO and ONOO− concentrations measured upon stimulation of cells by siNP 
at 10 µg/mL (D) and at 100 µg/mL (E).
Notes: All values are presented as the mean ± standard error of the mean of n = 4. One-way analysis of variance, Tukey–Kramer multiple comparison test: *P , 0.05, 
***P , 0.001 compared with 10 µg/mL 10siNP (D) and compared with 100 µg/mL 50siNP (E). 
Abbreviation: siNP, silica nanoparticles.
activation induced by silica nanoparticles correlated well 
with nanoparticle-induced oxidative stress (Figure 2).
When activated, NF-κB initiates the transcription of 
several genes involved in inflammation and coagulation.20,21 
Here, we demonstrate that the amorphous silica nanoparticles 
induced upregulation of ICAM1, VCAM1, SELE, MMP9, 
COX2, F3, IL6, and IL8 gene expression in a size-, time-, and 
concentration-dependent manner, when compared with controls 
in the absence of nanoparticles. Three-hour   exposure of primary 
HUVECs to a low concentration (10 µg/mL) of 10SiNP did 
not induce upregulation of gene expression   (Figure 5A). In 
contrast, a 7-hour exposure of primary HUVECs to an equal 
concentration of 10SiNP led to   significant upregulation of 
ICAM1, VCAM1, SELE, COX2, F3, and IL8 gene expression International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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(Figure 5B). Compared with 7 hours, after a 15-hour 
exposure of the cells to an equal concentration (10 µg/mL) of 
10SiNP, a greater upregulation of ICAM1, VCAM1, SELE, 
MMP9, COX2, and F3 gene expression (Figure 5C–H), 
but also IL6 and IL8 (Figure 6A and B) was observed. We 
compared this nanoparticle-induced gene upregulation at 
various concentrations after a 15-hour exposure with the 
effects of larger nanoparticles (Figures 5 and 6). We found 
that upregulation of gene expression was higher when 
the endothelial cells were exposed to increasingly higher 
concentrations of these nanoparticles, but lower when the 
size of these particles increased. Our real-time quantitative 
polymerase chain reaction studies (Figures 5 and 6) correlated 
directly with the unfavorable shift of the [NO]/[ONOO−] 
ratio derived from exposure of the endothelial cells to silica 
nanoparticles (Figure 2).
We also demonstrated that the use of the cell-permeable 
and irreversible proteasome inhibitor, lactacystin, that 
  suppresses NF-κB activity leading to downregulation of 
its target genes,38 significantly preventing upregulation of 
ICAM1, VCAM1, SELE, F3, and IL8 gene expression 
 ( Figure 7) induced by exposure of endothelial cells to 
  amorphous silica nanoparticles. However, this effect was not 
observed for the MMP9, COX2, and IL6 genes (Figure 7).
Our data also show that exposure of primary HUVECs to 
amorphous silica nanoparticles resulted in increased release 
of IL6 and IL8 proteins into the cell culture supernatant in a 
size-dependent and concentration-dependent manner when 
compared with controls in the absence of   nanoparticles 
 ( Figure 6C and D). Indeed, at 10 µg/mL, 10SiNP induced 
release of both cytokines. In contrast, an equal   concentration 
of larger nanoparticles failed to increase such a release. How-
ever, increasing concentrations of 50SiNP, 150SiNP, and 
500SiNP resulted in significant release of both IL6 and IL8.
Amorphous silica nanoparticles decrease 
viability of primary hUVeCs
Exposure of endothelial cells to amorphous silica nanopar-
ticles led to increased cell death (Figure 8). The smallest 
nanoparticles (10 nm) induced the highest cytotoxicity in a 
time-dependent and concentration-dependent manner. Larger 
nanoparticles (50, 150, and 500 nm) showed very limited or 
no cytotoxicity, even after a 30-hour exposure.
Discussion
The novel findings of our study are that amorphous silica 
nanoparticles when internalized into the cytoplasm of primary 
HUVECs rapidly stimulated NO release. This was followed 
by a greater generation of ONOO−, leading to an unfavorably 
low [NO]/[ONOO−] ratio that correlated well with SiNP-
induced inflammatory responses in endothelial cells. Indeed, 
we observed that silica nanoparticles stimulated NF-κB 
DNA binding activity and upregulation of ICAM1, VCAM1, 
SELE, MMP9, COX2, F3, IL6, and IL8 gene expression. 
NF-κB activation also led to increased ICAM1, VCAM1, 
SELE, F3, and IL8 gene expression. The inflammatory 
AB
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Figure 3 Amorphous siNP induce oxidative/nitroxidative stress in primary human 
umbilical vein endothelial cells. As denoted by green fluorescence, exposure of cells 
to 10 µg/mL 10siNP for 1 hour induced free radical production (D) when compared 
with the control in the absence of nanoparticles (B). The corresponding phase-
contract micrographs of control (A) and treated (B) cells suggest cell death by 
necrosis induced by siNP.
Note: scale bars represent 100 µm.
Abbreviation: siNP, silica nanoparticles.
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reactions were associated with increased cell death. All of 
these inflammatory and cytotoxic effects were augmented 
with increased nanoparticle concentration, but were inversely 
proportional to the size of the silica nanoparticles. In fact, 
the smallest silica nanoparticles (10 nm) induced the most 
severe toxic effects on endothelial cells.
We showed that silica nanoparticles rapidly interacted with 
the plasma membrane and internalized into primary HUVECs. 
Nanoparticle uptake by cells may typically occur through 
nonspecific diffusion and/or endocytosis.39 It is increasingly 
recognized that particles of very different materials (eg, mes-
oporous silica40) can enter into the cell easily by endocytosis 
and accumulate in lysosomes. Our electron micrographs seem 
to indicate that endocytosis was involved in silica nanoparticle 
uptake by endothelial cells, since they were found mainly encap-
sulated in vesicles. However, nonencapsulated nanoparticles 
were also observed. This may indicate that the nanoparticles 
were internalized into these cells by mechanisms other than 
endocytosis or, most likely, the content of vesicles/lysosomes 
was released into the cytosol following membrane rupture.
Our transmission electron microscopic studies also 
show formation of silica nanoparticle agglomerates. 
A study by Nishikawa et al41 showed the involvement of 
endothelial caveolae (striated round structures with dimen-
sions of 50–100 nm in both opening diameter and depth) 
in internalization of polysiloxane nanoparticles (diameter 
10–100 nm). The polysiloxane nanoparticles were trapped 
in caveolae in the plasma membrane, internalized into the 
cytosol, and localized in the perinuclear region. Moreover, 
they also suggested the involvement of other   pinocytosis 
pathways, including clathrin-coated pits (basket-like 
structures, 100–200 nm in diameter) and macropinocytosis, 
in the uptake of polysiloxane nanoparticles by endothelial 
cells. Amorphous silica nanoparticles may also internalize 
into HUVECs by caveolin-mediated endocytosis. However, 
some of the nanoparticle agglomerates we observed encapsu-
lated into vesicles in the cytoplasm and interacting with the 
endothelial plasma membrane had dimensions much larger 
than the typical dimensions of caveolae. Nanoparticles have 
a high surface area-to-volume ratio, which increases in the 
opposite direction to size. This property allows adsorption of 
organic molecules and macromolecules, such as proteins. The 
adsorption of proteins at nanoparticle surfaces spontaneously 
occurs as soon as particles are placed in a protein solution. 
It has been shown that the “protein corona” thus formed may 
have fundamental significance for bionano interactions.34 
Zeta potentials provide quantitative information on the 
stability of the particle. Higher zeta potential values (either 
positive or negative) indicate greater repulsion between 
particles, and therefore that the particles are more likely to 
remain dispersed. Therefore, the “protein corona”, along 
with fluid characteristics, hydrophobicity, and zeta potentials, 
Figure 5 Amorphous SiNP induce upregulation of endothelial gene expression of inflammatory mediators. Exposure of cells for 7 hours (B) but not 3 hours (A) to 10 µg/mL 
10siNP upregulated gene expression as recorded by real-time quantitative polymerase chain reaction. The effect of these nanoparticles on gene expression at 15 hours was 
compared with that of larger nanoparticles (C–H). silica nanoparticles upregulated gene expression in a size-, concentration-, and time-dependent manner. The expression 
of each gene, within each sample, was normalized against 18s rrNA expression and expressed relative to the control sample using the formula 2−(∆∆Ct).
Notes: All values are the means ± standard error of the mean of n = 4. By two-tailed student’s t-test, ^P , 0.05, ^^P , 0.01, and ^^^P , 0.001 compared with the control 
(A and B). By one-way analysis of variance, Tukey–Kramer multiple comparison test, *P , 0.05, **P , 0.01, and ***P , 0.001 compared with the control (C–H). Filled bars 
correspond to cells not exposed to nanoparticles (control) and open bars to cells exposed to nanoparticles.
Abbreviations:  siNP,  silica  nanoparticles;  ICAM1,  intercellular  adhesion  molecule  1;  VCAM1,  vascular  cell  adhesion  molecule  1;  seLe,  selectin  e;  MMP9,  matrix 
metalloproteinase 9; IL6, interleukin-6; IL8, interleukin-8; COX, cyclo-oxygenase; F3, tissue factor.
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can affect the formation of nanoparticle agglomerates in the 
biological environment.34,42
We suggest that the collision of silica nanoparticles with 
the endothelial plasma membrane and subsequent opening 
of calcium channels lead to uncoupling of endothelial nitric 
oxide synthase and generation of excessive amounts of 
peroxynitrite. There is convincing evidence that activation 
of stretch-activated calcium channels is linked to stimulation 
of endothelial nitric oxide synthase and rapid generation of 
NO and ONOO−.43 The kinetics of the penetration of the 
cell membrane by silica nanoparticles most likely involves 
a flux of calcium ions into the cytoplasm.44 Therefore, silica 
nanoparticles are likely to stimulate calcium-dependent NO 
release in endothelial cells. The process of increased and 
prolonged NO production leads to depletion of enzymatic 
substrates and cofactors and, eventually, to uncoupling of 
endothelial nitric oxide synthase.45 Uncoupled endothelial 
nitric oxide synthase can generate superoxide,16 which can 
rapidly react with NO to produce ONOO− and change the 
balance of [NO]/[ONOO−] unfavorably. The ratio of the 
maximal NO to the maximal ONOO− concentrations was 
used in this study as an indicator of oxidative/nitroxidative 
IL6 gene expression
C
o
n
t
r
o
l
1
5
1
0
1
8
1
1
0
2
5
5
0
1
1
0
5
0
1
0
0
1
1
0
5
0
1
0
0 0
1
2
3
4
5
8
9
10
11
12
13
*
*
*
***
* *
*
*
***
*
A
10SiNP 150SiNP 50SiNP
Nanoparticle concentration (µg/mL) Nanoparticle concentration (µg/mL)
Nanoparticle concentration (µg/mL) Nanoparticle concentration (µg/mL)
I
L
6
 
 
m
R
N
A
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
)
IL8 gene expression
C
o
n
t
r
o
l
1
5
1
0
1
8
1
1
0
2
5
5
0
1
1
0
5
0
1
0
0
1
1
0
5
0
1
0
0 0
20
40
80
90
100
110
120
200
250
300
***
***
***
B
10SiNP 150SiNP 50SiNP
I
L
8
 
 
m
R
N
A
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
)
IL6 protein release
C
o
n
t
r
o
l
1
5
1
0
1
8
1
1
0
2
5
5
0
1
1
0
5
0
1
0
0
1
1
0
5
0
1
0
0
0
2
4
6
8
*
*
*
***
***
*
*
*
***
***
C
10SiNP 150SiNP 50SiNP
I
L
6
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
)
IL8 protein release
C
o
n
t
r
o
l
1
5
1
0
1
8
1
1
0
2
5
5
0
1
1
0
5
0
1
0
0
1
1
0
5
0
1
0
0 0
5
10
15
20
25
******
***
*
*
***
***
D
10SiNP 150SiNP 50SiNP
I
L
8
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
)
500SiNP
500SiNP 500SiNP
500SiNP
*
*
*
*
***
Figure 6 Amorphous siNP induce upregulation of cytokine gene expression and cytokine release in primary human umbilical vein endothelial cells. A 15-hour exposure of 
primary human umbilical vein endothelial cells to nanoparticle-induced upregulation of IL6 (A) and IL8 (B) gene expression, as well as an increased cytokine (C IL6 and D 
IL8) release into the cell culture supernatant in a concentration-dependent and size-dependent manner. The expression of each gene, within each sample, was normalized 
against 18s rrNA expression and expressed relative to the control sample using the formula 2−(∆∆Ct). (A and B). The cytokine release induced by each nanoparticle treatment 
is expressed relative to the control sample (C and D).
Notes: All values are presented as the mean ± standard error of the mean of n = 4. By one-way analysis of variance, Tukey–Kramer multiple comparison test, *P , 0.05, 
**P , 0.01, and ***P , 0.001 compared with the control (A–D). Filled bars correspond to cells which were not exposed to nanoparticles (control) and open bars to cells 
exposed to nanoparticles. 
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stress leading to endothelial dysfunction. At high levels of 
cytoprotective NO and/or low levels of cytotoxic ONOO−, 
this ratio is high (.2.0) indicating coupled endothelial nitric 
oxide synthase and normal endothelial function. A low ratio 
(,1.0) is associated with dysfunctional endothelium. An 
extremely low ratio (,0.5) is indicative of severe uncoupled 
endothelial nitric oxide synthase and dysfunctional endothe-
lium accompanied by high nitroxidative/oxidative stress.16,18 
Our data show that exposure of endothelial cells to silica 
nanoparticles resulted in a very low [NO]/[ONOO−] ratio, 
especially for 10SiNP (0.11 ± 0.02, at 10 µg/mL), indicative 
of severe uncoupling of endothelial nitric oxide synthase, 
oxidative/nitroxidative stress, cell dysfunction, and   necrosis. 
This high oxidative/nitroxidative stress reflected by high 
ONOO− production and a low [NO]/[ONOO−] balance 
directly triggers a chain of reactions leading to endothelial 
inflammatory responses.19 This is evidenced by the ability 
of the amorphous silica nanoparticles to induce transcription 
factor activation (eg, NF-κB) and eventually increased gene 
expression (eg, ICAM1, VCAM1, SELE, MMP9, COX2, F3, 
IL6, and IL8) and cytokine release (eg, IL6 and IL8).
We found that the amorphous silica nanoparticles induced 
increased endothelial NF-κB activity which was inversely 
proportional to the size of the nanoparticles. These data are 
also consistent with the ability of other nanoparticles to influ-
ence transcription factor activity; for instance, carbon black 
(14 nm) increases the activity of NF-κB and AP-1 in the A595 
lung epithelial cell line in 1 hour.46 Also, crystalline silica has 
been shown to induce production of inflammatory mediators 
by activation of NF-κB in a RAW 264.7 mouse macrophage 
cell line.47 When activated, NF-κB initiates the transcription 
of several genes involved in inflammation and coagulation.20,21 
Our data show that amorphous silica nanoparticle-induced 
upregulation of ICAM1, VCAM1, SELE, MMP9, COX2, F3, 
IL6, and IL8 gene expression in a fashion which was directly 
proportional to incubation time and nanoparticle concentra-
tion, but inversely proportional to nanoparticle size. However, 
use of lactacystin significantly prevented the expression of 
ICAM1, VCAM1, SELE, F3, and IL8. These observations 
indicate that other transcription factors (eg, AP-1) may also 
be involved in the endothelial inflammation induced by amor-
phous silica nanoparticles. Our data also show that exposure 
of primary HUVECs to amorphous silica nanoparticles led 
to increased cytokine release. Interestingly, upregulation of 
cytokine IL8 gene expression induced by silica nanoparticles, 
measured by real-time qualitative polymerase chain reaction, 
was always much higher than that of protein release measured 
by cytometric bead array. These differences may be explained 
by the fact that IL8 can be stored in Weibel-Palade bodies in 
the cytoplasm of endothelial cells.48 In contrast, gene upregu-
lation of IL6 and protein release (fold-to-fold comparison) 
correlated well. Our data are in agreement with previous 
studies. For instance, it has been shown that engineered metal 
oxide particles upregulate ICAM1 and IL8 gene expression in 
human aortic endothelial cells.49 Further, silica nanoparticles 
induce the expression of IL8 in human dermal microvascular 
endothelial cells.50 Furthermore, oxidative stress-mediated 
NF-κB activation by silica nanoparticles has been suggested 
to increase expression of ICAM1, VCAM1, and SELE, as 
well as release of F3 and IL8 proteins in endothelial cells.37 
The inflammatory responses induced by silica nanoparticles in 
endothelial cells reported here are similar to those induced in 
the endothelium in vivo by interleukin 1β and tumor necrosis 
factor-α in the absence of infection.20 These responses corre-
lated directly with an unfavorable shift of the [NO]/[ONOO−] 
ratio, leading to oxidative/nitroxidative stress arising from 
exposure of endothelial cells to silica nanoparticles.
We also demonstrated the ability of amorphous 
  silica nanoparticles to decrease endothelial cell viability. 
These results were observed in direct proportion to incu-
bation time and nanoparticle concentration, but inversely 
C
o
n
t
r
o
l
0
1
0
1
0
1
0
1
0
1
0
1
0
1
0
1
0
10
20
30
40
50
70
80
90
100
ICAM1 MMP9 SELE VCAM1 IL8 COX2 F3 IL6
* *
*
*
* *
*
*
Lactacystin (µM)
m
R
N
A
 
(
f
o
l
d
 
i
n
c
r
e
a
s
e
)
Figure 7 Amorphous SiNP induce upregulation of gene expression of inflammatory 
mediators by NF-κB activation in primary human umbilical vein endothelial cells. 
Upregulation of gene expression of ICAM1, VCAM1, seLe, F3, and IL8 derived from 
exposure of cells to 10siNP (10 µg/mL) was significantly lower in the present of 
lactacystin 1 µM indicating that NF-κB was involved in their expression. expression 
of each gene, within each sample, was normalized against 18s rrNA expression and 
expressed relative to the control sample using the formula 2−(∆∆Ct).
Notes: Two-tailed student’s t-test: *P , 0.05, **P , 0.01, ***P , 0.001 compared 
with controls in the presence of siNP but in the absence of lactacystin. Filled bars 
correspond to cells which were not exposed to nanoparticles (control) and open 
bars to cells exposed to nanoparticles in the present (1 µM) or absence (0) of 
lactacystin.
Abbreviations:  siNP,  silica  nanoparticles;  ICAM1,  intercellular  adhesion 
molecule 1; VCAM1, vascular cell adhesion molecule 1; seLe, selectin e; MMP9, 
matrix  metalloproteinase  9;  IL6,  interleukin-6;  IL8,  interleukin-8;  COX,  cyclo-
oxygenase; F3, tissue factor.International Journal of Nanomedicine  2011: 6 submit your manuscript | www.dovepress.com
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proportional to nanoparticle size. Napierska et al also 
showed size-dependent cytotoxicity of silica nanoparticles 
in EAHY926 cells.51
In summary, amorphous silica nanoparticles penetrated 
the plasma membrane of endothelial cells and stimulated 
rapid NO release. The rapid increase and prolonged pro-
duction of NO lead to an uncoupling of endothelial nitric 
oxide synthase and generation of ONOO−, that eventually 
produced an overall decrease in the [NO]/[ONOO−] ratio. An 
increase in the level of oxidative/nitroxidative stress induced 
by ONOO− decreased the bioavailability of cytoprotective 
NO. The depleted NO and increased ONOO− production 
resulting in a low endothelial [NO]/[ONOO−] balance was 
inversely proportional to nanoparticle size, but in direct 
correlation with particle concentration, and inflammatory 
and cytotoxic responses. This article provides for the first 
time quantitative and qualitative data linking the deleterious 
effects of silica nanoparticles directly to dysfunction of 
endothelial nitric oxide synthase and overproduction of 
ONOO−. Amorphous silica nanoparticles have toxic effects 
on endothelial cells and may impair vascular homeostasis. 
These effects are especially severe for silica nanoparticles 
smaller than 50 nm.
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Figure 8 Amorphous siNP induce cytotoxicity in primary human umbilical vein endothelial cells. exposure of cells to 10siNP (A) and 50siNP (B) significantly decreased 
cell viability. In contrast, 150siNP (C) and 500siNP (D) failed to do so, even after a 30-hour incubation at a 100 µg/mL nanoparticle concentration. Cell viability after each 
nanoparticle treatment was expressed relative to the control sample.
Notes: All values are presented as the mean ± standard error of the mean of n = 4. One-way analysis of variance, Tukey–Kramer multiple comparison test: *P , 0.05, 
**P , 0.01, ***P , 0.001 compared with the control. Filled bars correspond to cells which were not exposed to nanoparticles (control) and open bars to cells exposed to 
nanoparticles.
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